Salem Investment Counselors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$2.13M |
| 2 |
Advanced Micro Devices
AMD
|
+$1.21M |
| 3 |
Hubbell
HUBB
|
+$842K |
| 4 |
Fabrinet
FN
|
+$568K |
| 5 |
Red Violet
RDVT
|
+$565K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$185M |
| 2 |
Palantir
PLTR
|
+$33.5M |
| 3 |
NVIDIA
NVDA
|
+$11M |
| 4 |
Micron Technology
MU
|
+$5.06M |
| 5 |
Green Brick Partners
GRBK
|
+$4.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.52% |
| 2 | Consumer Discretionary | 20.81% |
| 3 | Financials | 10.16% |
| 4 | Healthcare | 9.11% |
| 5 | Communication Services | 8.38% |
Similar funds
Salem Investment Counselors's Q4 2024 Portfolio in Review
As of Q4 2024, Salem Investment Counselors held 1,285 positions worth $3.05B, down 8.2% from $3.32B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Salem Investment Counselors withdrew a net $284M in Q4 2024, closing 82 positions and reducing 302 holdings. Its most notable exit was Stericycle Inc, an estimated $549K position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Salem Investment Counselors opened a new position in Fabrinet worth $518K.
- Salem Investment Counselors's largest Q4 2024 buy was Fabrinet: 2,355 shares worth $518K.
- Salem Investment Counselors added most to Evolent Health in Q4 2024, an estimated $2.13M increase.
- Salem Investment Counselors's biggest Q4 2024 reduction was Lowe's Companies, cutting an estimated $185M.
- Salem Investment Counselors fully exited Stericycle Inc in Q4 2024, selling an estimated $549K.
- Salem Investment Counselors's ten largest holdings make up 49% of its $3.05B portfolio in Q4 2024.
- Salem Investment Counselors opened 98 new positions and closed 82 in Q4 2024.
- Salem Investment Counselors's portfolio value fell 8.2% quarter-over-quarter to $3.05B.
Based on Salem Investment Counselors's 13F filing for Q4 2024, filed 13 Jan 2025.